Cite Filings / TLSI / 0001104659-26-064507

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

TriSalus Life Sciences, Inc. Filed 2026-05-20 Acc 0001104659-26-064507

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-07-07 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-20 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-19 4 Chief Commercial Officer sold 543 shares at $2.67 ($1,450)
2026-05-18 4 Director bought 60,000 shares at $2.53 ($151,800)
2026-05-18 4 Director bought 610,000 shares at $2.50 ($1,525,000)
2026-05-18 4 CEO and President bought 39,682 shares at $2.59 ($102,776)
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…